CAS: 402-71-1; (S)-N-(4-Chloro-3-Oxo-1-Phenylbutan-2-yl)-4-Methylbenzenesulfonamide

该化合物是一种合成蛋白抑制剂,主要用于通过对活性地点的丁丁酸残留物进行烷基处理,从而停止除精蛋白蛋白质,特别是丙烯菊酯,其特性和不可逆的结合使其成为研究酶机制和蛋白相互作用的生物化学研究的宝贵工具.TPCK在防止蛋白净化和细胞液化准备过程中出现不想要的蛋白解降解方面特别有效.该化合物的稳定性和选择性确保了酶学和分子生物学应用的可靠实验结果.适当的处理由于它的再活动性而必不可少,并且通常用于控制浓度以达到最佳抑制,同时尽量减少非特定影响.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    (S)-N-(4-(Dimethyl(Oxo)-L6-Sulfaneylidene)-3-Oxo-1-Phenylbutan-2-yl)-4-Methylbenzenesulfonamide置于甲烷磺酸,Lithium Chloride体系中,用 四氢呋喃 作为反应溶剂,以2.25 G的收率获得产物n-(对甲苯磺酰基)-L-苯丙氨酰甲基氯酮
    参考文献:N-甲苯磺酰基-L-苯丙氨酸氯甲基酮的简便制备
    标题:N-甲苯磺酰基-L-苯丙氨酸氯甲基酮的简便制备
    摘要:开发了一种简便制备n-甲苯磺酰基-L-苯丙氨酸氯甲基酮的方法.l-苯丙氨酸被甲苯磺酸化并转化为对硝基苯酚的活化酯.随后与二甲基亚砜基亚甲基反应,并用氯化锂和甲磺酸处理,得到α-氯酮.该实用程序避免了使用有毒易爆的重氮甲烷.
    DOI:10.2174/157017809790443005

    海关参考信息

    专利信息


    专利号:WO-2024153752-A1
    优先权日:2023-01-20
    标 题 :Stereoselective synthesis of intermediates and synthesis of quinagolids
    发明人:RYBERG PER; PINESCHI MAURO; COMPARINI LUCREZIA
    权利人:FERRING BV
    摘要:Disclosed is a method for preparing compounds with improved stereoselectivities. The described compounds are useful intermediates and may find particular application in the synthesis of compounds containing an octahydrobenzoquinoline moiety (e.g. an octahydrobenzo[g]quinoline moiety), such as quinagolide and its derivatives. Also disclosed is a method for stereoselectively (e.g. enantioselectively) preparing an intermediate used in the existing manufacturing process for the synthesis of quinagolide this intermediate also finding utility in the synthesis of other compounds containing an octahydrobenzo[g]quinoline moiety, in particular those having a substituent at the 3- position on the octahydrobenzo[g]quinoline.

    专利号:WO-2024079704-A1
    优先权日:2022-10-13
    标题 :Synthesis of derivatives of siphonochilone and therapeutic use thereof
    发明人:INVERNIZZI LUKE; MOYO PHANANKOSI; MAHARAJ VINESH
    权利人:UNIV PRETORIA
    摘要:THIS invention relates to the synthesis of derivatives of siphonochilone and therapeutic use thereof in the treatment and prevention of respiratory virus disease, in particular influenza or a coronavirus disease.

    专利号:US-7829669-B2
    优先权日:1999-06-28
    标 题:Catalytically active recombinant memapsin and methods of use thereof
    发明人:KOELSCH GERALD; TANG JORDAN J N; HONG LIN; GHOSH ARUN K; LIN XINLI
    权利人:OKLAHOMA MED RES FOUND; UNIV ILLINOIS
    摘要:Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1 ). The inhibition constant of OM99-2 is 1.6×10 −9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bond to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.

    专利号:US-4634671-A
    优先权日:1982-09-18
    标 题 :Water-soluble cross-linked polymer of lysyl endopeptidase, process for preparing same and use of same
    发明人:SAKATA YOSHITSUGU; SHINTANI AKINORI; MATSUO TETSUYA; SUGIYAMA HARUHIKO; TOKIOKA NOBUYUKI
    权利人:WAKO PURE CHEM IND LTD
    摘要:A water-soluble cross-linked polymer of the enzyme lysyl endopeptidase produced by Achromobacter lyticus and a process for preparing the polymer as well as a semi-synthesis of human insulin using the polymer.

    专利号:US-2002049303-A1
    优先权日:1999-06-28
    标 题 :Catalytically active recombinant memapsin and methods of use thereof
    发明人:TANG JORDAN J N; LIN XINLI; KOELSCH GERALD; HONG LIN
    摘要:Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogs including isosteres at the sites of the critical amino acid residues were developed and the substrate analogs, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1 ). The inhibition constant of OM99-2 is 1.6×10 −9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bound to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.

    专利号:SA-02230453-B1
    优先权日:2001-09-07
    标 题 :Methods for the synthesis of conjugate products of an insulin polypeptide with an oligomer, and conjugate products of a proinsulin polypeptide with an oligomer (and methods for their synthesis)
    上海佰特因医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.better-in.com
    电话: 021-38921049 13564871374👤
    📞上海佰特因医药科技有限公司 ⚠️参考联系方式

    销售电话:021-38921049 13564871374
    邮箱:sales@better-in.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Pauly PC, Klein C. An uncleaved glycosylphosphatidylinositol signal mediates Ca(2+)-sensitive protein degradation. Biochem J. 1996 Jul 15;317 ( Pt 2):533-40.
    2: Mizuguchi J, Utsunomiya N, Nakanishi M, Arata Y, Fukazawa H. Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells. Biochem J. 1989 Nov 1;263(3):641-6.
    3: Braun NJ, Schnebli HP. Interaction of Eglin c with polymorphonuclear cells: evidence for binding to the cell surface. Biol Chem Hoppe Seyler. 1987 Feb;368(2):155-61.

    合成参考文献


    参考文献:10.1016/j.bbrc.2011.06.195
    摘要:Hwang I, Ha D, Ahn G, Park E, Joo H, Jee Y. Experimental autoimmune encephalomyelitis: Association with mutual regulation of RelA (p65)/NF-κB and phospho-IκB in the CNS. Biochemical and Biophysical Research Communications. 2011 Jul;411(2):464–70. doi: 10.1016/j.bbrc.2011.06.195.
    参考文献:10.1016/j.bmc.2011.06.069
    摘要:Zhang L, Feng L, Jia Q, Xu J, Wang R, Wang Z, Wu Y, Li Y. Effects of β-glucosidase hydrolyzed products of harpagide and harpagoside on cyclooxygenase-2 (COX-2) in vitro. Bioorg Med Chem. 2011 Aug 15;19(16):4882–6. doi: 10.1016/j.bmc.2011.06.069.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知